Nontuberculous mycobacterial pulmonary disease diagnosed by two methods: a prospective cohort study

被引:16
作者
Kim, Hyung-Jun [1 ]
Lee, Jong Hyuk [2 ]
Yoon, Soon Ho [2 ]
Kim, Sung A. [1 ]
Kim, Myoung Sil [1 ]
Choi, Sun Mi [1 ]
Lee, Jinwoo [1 ]
Lee, Chang-Noon [1 ]
Han, Sung Koo [1 ]
Yim, Jae-Joon [1 ]
机构
[1] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Internal Med, Div Pulm & Crit Care Med,Coll Med, 101 Daehak Ro, Seoul 03080, South Korea
[2] Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea
关键词
Clinical medicine; Cohort studies; Diagnosis; Nontuberculous mycobacteria; Progression; LUNG-DISEASE; INDUCED SPUTUM; EPIDEMIOLOGY; AVIUM; ABSCESSUS; IDENTIFICATION; TUBERCULOSIS; PROGRESSION;
D O I
10.1186/s12879-019-4078-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundMicrobiological criteria for diagnosing nontuberculous mycobacterial pulmonary disease (NTM-PD) include positive culture results from at least two separately expectorated sputum specimens or one bronchial washing or lavage. However, the clinical similarities and differences between patients diagnosed by these two methods remain unclear. We compared clinical features and prognoses of patients with NTM-PD diagnosed from both specimen types.MethodsWe analysed data from patients who participated in the Seoul National University Hospital NTM-PD cohort (ClinicalTrials.gov identifier: NCT01616745). Baseline demographics, symptoms, radiographic findings, disease progression, and treatment responses were summarized and compared between patients diagnosed from sputum specimens and patients diagnosed from bronchoscopic specimens.ResultsThree hundred forty-seven patients were included in the analyses. Of these, 279 (80.4%) were diagnosed from two separately expectorated sputum specimens, and 68 (19.6%) were diagnosed from bronchoscopic specimens. Patients diagnosed from sputum specimens had more frequent and severe cough, sputum, postnasal drip, and high St. George's Respiratory Questionnaire scores. However, the extent and severity of the radiographic lesions, disease progression, and treatment responses were similar for both groups. Further analysis based on the following three groups (sputum culture positive, sputum culture negative/bronchoscopy, and scanty sputum/bronchoscopy groups) suggested that the scanty sputum/bronchoscopy group appeared to have the worst prognosis in terms of both time to progression and time to culture conversion.ConclusionsAlthough some symptoms and quality of life were worse in patients with NTM-PD diagnosed from sputum specimens, their prognoses were similar to those of patients diagnosed by bronchoscopic specimen. We recommend bronchoscopic sampling for patients in whom NTM-PD is suspected clinically or radiographically, especially those who have no or scanty sputum.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Nontuberculous mycobacterial pulmonary disease
    Johnson, Margaret M.
    Waller, Ernest Andrew
    Leventhal, Jack P.
    CURRENT OPINION IN PULMONARY MEDICINE, 2008, 14 (03) : 203 - 210
  • [32] Nontuberculous mycobacterial pulmonary disease
    Ringshausen, F. C.
    Rademacher, J.
    INTERNIST, 2016, 57 (02): : 142 - 151
  • [33] A Prospective Cohort Study of Bioavailable 25-Hydroxyvitamin D Levels as a Marker of Vitamin D Status in Nontuberculous Mycobacterial Pulmonary Disease
    Kwon, Byoung-Soo
    Lee, Kyunghoon
    Kim, Eun-Sun
    Jun, Sun-Hee
    Lim, Sung-Yoon
    Song, Myung-Jin
    Kim, Yeon-Wook
    Lee, Yeon-Joo
    Park, Jong-Sun
    Cho, Young-Jae
    Yoon, Ho-Il
    Lee, Choon-Taek
    Song, Junghan
    Lee, Jae-Ho
    NUTRIENTS, 2021, 13 (08)
  • [34] Characteristics associated with progression in patients with of nontuberculous mycobacterial lung disease : a prospective cohort study
    Soo Jung Kim
    Soon Ho Yoon
    Sun Mi Choi
    Jinwoo Lee
    Chang-Hoon Lee
    Sung Koo Han
    Jae-Joon Yim
    BMC Pulmonary Medicine, 17
  • [35] Nontuberculous Mycobacterial Pulmonary Disease in the Immunocompromised Host
    Varley, Cara D.
    Streifel, Amber C.
    Bair, Amanda M.
    Winthrop, Kevin L.
    CLINICS IN CHEST MEDICINE, 2023, 44 (04) : 829 - 838
  • [36] Comparison of frailty in patients with nontuberculous mycobacterial lung disease and bronchiectasis: a prospective cohort study
    Kohei Fujita
    Yutaka Ito
    Yuki Yamamoto
    Osamu Kanai
    Takuma Imakita
    Issei Oi
    Takanori Ito
    Zentaro Saito
    Tadashi Mio
    BMC Pulmonary Medicine, 22
  • [37] Nonpharmacological Treatment for Nontuberculous Mycobacterial Pulmonary Disease
    Kim, Hyung-Jun
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2024, 87 (04) : 451 - 457
  • [38] Clinical Features of Nontuberculous Mycobacterial Pulmonary Disease in the Yangtze River Delta of China: A Single-Center, Retrospective, Observational Study
    Lou, Hai
    Zou, Ansheng
    Shen, Xiaona
    Fang, Yong
    Sun, Qin
    Zhang, Fen
    Sha, Wei
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2023, 8 (01)
  • [39] Usefulness of the BACES score in nontuberculous mycobacterial pulmonary disease for various clinical outcomes
    Kim, Hyung-Jun
    Song, Myung Jin
    Kwon, Byoung Soo
    Kim, Yeon Wook
    Lim, Sung Yoon
    Lee, Yeon-Joo
    Park, Jong Sun
    Cho, Young-Jae
    Lee, Choon-Taek
    Lee, Jae Ho
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [40] Microbiological Diagnosis of Nontuberculous Mycobacterial Pulmonary Disease
    van Ingen, Jakko
    CLINICS IN CHEST MEDICINE, 2015, 36 (01) : 43 - 54